NAIINasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends June 30
NATURAL ALTERNATIVES INTERNATIONAL INC
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-K on Sep 28, 2026
$1.15+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.98M
- P/E (TTM)
- –
- Dividend yield
- –
NATURAL ALTERNATIVES INTERNATIONAL INC revenue by segment
By business segment
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Private Label Contract Manufacturing [Member] | $134.62M | $134.44M | $127.70M | $127.21M | $121.78M | $117.66M | $113.06M | $103.80M | $105.36M | $110.04M | $117.92M | $135.71M | 94.5% | +10.5% |
| Patent and Trademark Licensing [Member] | $7.90M | $7.44M | $7.46M | $7.23M | $8.08M | $7.82M | $8.79M | $9.18M | $8.44M | $10.16M | $9.85M | $9.15M | 5.5% | -2.2% |
| Operating income | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patent and Trademark Licensing [Member] | $2.69M | $2.79M | $2.98M | $3.12M | $3.41M | $3.17M | $3.64M | $3.87M | $3.32M | $4.13M | $3.72M | $3.12M | -21.0% |
| Private Label Contract Manufacturing [Member] | -$12.45M | -$23.00K | $1.70M | $719.00K | -$1.73M | -$3.46M | -$3.91M | -$5.12M | -$3.47M | $860.00K | $624.00K | $7.26M | +621.0% |
By product or service
By region
| Revenue | TTM Q4 26 | TTM Q3 26 | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States | – | – | – | – | $79.13M | $76.16M | $73.36M | $69.20M | $73.51M | $83.27M | $92.07M | $104.39M | – | – |
| Non-US [Member] | – | – | – | – | $50.73M | $49.33M | $48.49M | $43.78M | $40.28M | $36.93M | $35.70M | $40.47M | – | – |
From the segment and revenue-disaggregation notes of Natural Alternatives International's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.